CLDT Earnings

CLDT reported its earnings on 2026-02-25, showcasing a revenue of against an estimate of 67.37M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.16 by 0%. The stock experienced a 1.23% price change on the earnings day and a 4.51% change over the next five days, reflecting market reactions to the results.

Following CLDT's earnings announcement on 2026-02-25, the stock price moved by 1.23% on the day of the release. Over the subsequent five days, it saw a 4.51% change. Historically, CLDT's stock price tends to shift by an average of 2.37% in the 10 days leading up to earnings and -0.09% in the 10 days following, providing insight into potential market.

For 2025/Q2, analysts estimate CLDT's annual revenue to reach 79.67M, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised upward by 9.85% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CLDT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised upward by 9.85%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CLDT's stock price typically moves by 2.37% in the 10 days before its earnings and -0.09% in the 10 days after. For the upcoming 2025/Q2 earnings, analysts expect an EPS of undefined and revenue of 79.67M.

The earnings call presents a mixed picture: RevPAR is expected to decline, but there are positive signs like increased share repurchases and dividends, debt reduction, and stable margins. The Q&A highlights uncertainties in asset sales and the Portland development, while management remains conservative on World Cup impacts. Despite some positive indicators, the overall sentiment is cautious due to RevPAR declines and lack of clarity on certain strategic moves, resulting in a neutral outlook for the stock price.